XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 3 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Cash flows from operating activities:    
Net income $ 123,600,000 $ 50,700,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 292,800,000 307,100,000
Deferred income taxes (49,400,000) (16,800,000)
Share-based compensation expense related to equity incentive plans 42,400,000 40,700,000
Loss on settlement of debt 26,800,000 1,900,000
Amortization of debt discount 25,300,000 29,900,000
Amortization of debt issuance costs 4,800,000 4,200,000
Gains on sale of assets (900,000) 0
Impairment of intangible assets 0 500,000
Gains on available-for-sale investments and marketable equity securities, net (200,000) (800,000)
Other non-cash adjustment 500,000 (100,000)
Changes in operating assets and liabilities, excluding impact of acquisitions:    
Decrease (increase) in accounts receivable 39,700,000 (56,200,000)
Decrease (increase) in inventories 24,900,000 (20,500,000)
(Decrease) increase in accounts payable and accrued liabilities (46,600,000) 49,700,000
Change in other assets and liabilities 1,400,000 14,400,000
Change in income tax payable 16,700,000 (24,100,000)
Net cash provided by operating activities 501,800,000 380,600,000
Cash flows from investing activities:    
Investments in other assets (7,600,000) (2,600,000)
Proceeds from sale of assets 200,000 200,000
Capital expenditures (9,500,000) (23,900,000)
Net cash used in investing activities (16,900,000) (26,300,000)
Cash flows from financing activities:    
Payments on settlement of convertible debt (1,027,200,000) 0
Proceeds from issuance of senior notes 2,182,000,000.0 0
Repayment of bridge loan facility (615,000,000.0) 0
Deferred financing costs (5,200,000) 0
Payment of cash dividends (90,400,000) (87,100,000)
Proceeds from sale of common stock 11,000,000.0 7,300,000
Tax payments related to shares withheld for vested restricted stock units (11,000,000.0) (11,400,000)
Capital lease payments (200,000) (200,000)
Net cash used in financing activities (507,700,000) (348,900,000)
Net (decrease) increase in cash and cash equivalents (22,800,000) 5,400,000
Cash and cash equivalents, and restricted cash at beginning of period 401,000,000.0 428,600,000
Cash and cash equivalents, and restricted cash at end of period 378,200,000 434,000,000.0
Supplemental disclosure of cash flow information    
Restricted Cash 0 38,800,000
Term Loan Facility    
Cash flows from financing activities:    
Repayments of loan facility (17,800,000) (188,000,000.0)
Revolving Credit Facility    
Cash flows from financing activities:    
Repayments of loan facility (2,171,900,000) (273,500,000)
Proceeds from borrowings on revolving loan under credit facility $ 1,238,000,000.0 $ 204,000,000.0